IL132166A0 - Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses - Google Patents

Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses

Info

Publication number
IL132166A0
IL132166A0 IL13216698A IL13216698A IL132166A0 IL 132166 A0 IL132166 A0 IL 132166A0 IL 13216698 A IL13216698 A IL 13216698A IL 13216698 A IL13216698 A IL 13216698A IL 132166 A0 IL132166 A0 IL 132166A0
Authority
IL
Israel
Prior art keywords
radical
seq
peptide sequence
formula
val
Prior art date
Application number
IL13216698A
Other languages
English (en)
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26233456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132166(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9704356A external-priority patent/FR2761993B1/fr
Priority claimed from FR9802212A external-priority patent/FR2775287B1/fr
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Publication of IL132166A0 publication Critical patent/IL132166A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13216698A 1997-04-09 1998-04-06 Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses IL132166A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704356A FR2761993B1 (fr) 1997-04-09 1997-04-09 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
FR9802212A FR2775287B1 (fr) 1998-02-24 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
PCT/FR1998/000691 WO1998045323A1 (fr) 1997-04-09 1998-04-06 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih-1 du groupe o

Publications (1)

Publication Number Publication Date
IL132166A0 true IL132166A0 (en) 2001-03-19

Family

ID=26233456

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13216698A IL132166A0 (en) 1997-04-09 1998-04-06 Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses
IL132166A IL132166A (en) 1997-04-09 1999-09-30 Synthetic peptides used in biological tests to detect infections caused by viruses belonging to group O HIV-1

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132166A IL132166A (en) 1997-04-09 1999-09-30 Synthetic peptides used in biological tests to detect infections caused by viruses belonging to group O HIV-1

Country Status (20)

Country Link
US (2) US7053175B1 (xx)
EP (1) EP0973802B1 (xx)
JP (1) JP3560987B2 (xx)
KR (1) KR100451312B1 (xx)
CN (1) CN1215082C (xx)
AT (1) ATE343590T1 (xx)
AU (1) AU740231B2 (xx)
BR (1) BRPI9809078B8 (xx)
CA (1) CA2286344C (xx)
CZ (1) CZ300927B6 (xx)
DE (1) DE69836265T2 (xx)
ES (1) ES2275305T3 (xx)
IL (2) IL132166A0 (xx)
NO (1) NO329149B1 (xx)
NZ (1) NZ500015A (xx)
PL (1) PL194863B1 (xx)
PT (1) PT973802E (xx)
RU (1) RU2184742C2 (xx)
TR (1) TR199902757T2 (xx)
WO (1) WO1998045323A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI9809078B8 (pt) * 1997-04-09 2021-05-25 Bio Rad Innovations peptídeo sintético utilizáveis nos testes biológicos para a detecção das infecções devido aos vírus hiv1 do grupo o, composição que os compreende, processo de imunodosagem in vitro e kit de diagnóstico.
CA2676762C (en) * 1998-11-30 2015-12-29 Ortho-Clinical Diagnostics, Inc. Peptides for the detection of hiv-1 group o
FR2874017B1 (fr) * 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
US9658220B2 (en) 2012-06-22 2017-05-23 Bio-Rad Laboratories, Inc. Human factor XIII as a normalization control for immunoassays
CN112481246B (zh) * 2020-12-16 2022-03-29 熊猫乳品集团股份有限公司 一种生物活性多肽fspankkltpkky及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204259A (en) 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
JP3277045B2 (ja) 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Hiv−グループのレトロウイルスおよびその使用
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
GB9410044D0 (en) * 1994-05-19 1994-07-06 Int Murex Tech Corp Assay
DE4430972A1 (de) 1994-07-25 1996-02-01 Boehringer Mannheim Gmbh Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene
US6399294B1 (en) * 1994-10-20 2002-06-04 Institut Pasteur Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
DE19505262C2 (de) 1995-02-16 1998-06-18 Behring Diagnostics Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
FR2731013B1 (fr) * 1995-02-27 1997-05-16 Inst Nat Sante Rech Med Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
WO1996027012A1 (en) 1995-03-02 1996-09-06 Akzo Nobel N.V. Specific hiv-1 group o antigens
US5569553A (en) 1995-03-08 1996-10-29 Wilson Greatbatch Ltd. Battery design for achieving end-of-life indication during electrical discharge
DE19622088A1 (de) 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben
BRPI9809078B8 (pt) * 1997-04-09 2021-05-25 Bio Rad Innovations peptídeo sintético utilizáveis nos testes biológicos para a detecção das infecções devido aos vírus hiv1 do grupo o, composição que os compreende, processo de imunodosagem in vitro e kit de diagnóstico.
EP1003878A2 (en) 1997-07-18 2000-05-31 Innogenetics N.V. Hiv-1 group o antigens and uses thereof

Also Published As

Publication number Publication date
WO1998045323A1 (fr) 1998-10-15
TR199902757T2 (xx) 2000-02-21
NO994929D0 (no) 1999-10-08
CN1256695A (zh) 2000-06-14
DE69836265D1 (de) 2006-12-07
AU7338698A (en) 1998-10-30
NO994929L (no) 1999-12-08
BR9809078B1 (pt) 2012-12-11
CA2286344C (fr) 2012-08-07
JP2001519800A (ja) 2001-10-23
CZ357599A3 (cs) 2000-06-14
CZ300927B6 (cs) 2009-09-16
PL336115A1 (en) 2000-06-05
EP0973802B1 (fr) 2006-10-25
PL194863B1 (pl) 2007-07-31
AU740231B2 (en) 2001-11-01
US7838001B2 (en) 2010-11-23
DE69836265T2 (de) 2007-05-31
BR9809078A (pt) 2000-08-01
US20060234213A1 (en) 2006-10-19
US7053175B1 (en) 2006-05-30
NO329149B1 (no) 2010-08-30
CN1215082C (zh) 2005-08-17
PT973802E (pt) 2007-01-31
KR20010006216A (ko) 2001-01-26
JP3560987B2 (ja) 2004-09-02
NZ500015A (en) 2001-06-29
EP0973802A1 (fr) 2000-01-26
ES2275305T3 (es) 2007-06-01
ATE343590T1 (de) 2006-11-15
BRPI9809078B8 (pt) 2021-05-25
CA2286344A1 (fr) 1998-10-15
KR100451312B1 (ko) 2004-10-06
IL132166A (en) 2006-12-10
RU2184742C2 (ru) 2002-07-10

Similar Documents

Publication Publication Date Title
Savage et al. Epidermal growth factor: location of disulfide bonds
Karplus et al. Amino acid sequence of spinach ferredoxin: NADP oxidoreductase
Denkewalter et al. Total synthesis of an enzyme. I. Objective and strategy
GB9720054D0 (en) Biological products
DE68913935T2 (de) Verfahren zur Herstellung von Retro-Inverso-Peptiden und dessen Zwischenprodukte.
BRPI0511005A (pt) peptìdeos oligoméricos e seu uso para o tratamento de infecções por hiv
Huang et al. Egg White Avidin: II. ISOLATION, COMPOSITION, AND AMINO ACID SEQUENCES OF THE TRYPTIC PEPTIDES
IL132166A0 (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses
Kress et al. The Basic Trypsin Inhibitor of Bovine Pancreas: IX. LOCATION OF THE REACTIVE SITE IN THE CARBOXAMIDOMETHYL DERIVATIVE
König et al. The amino acid sequence of the peptide moiety of the pseudomurein from Methanobacterium thermoautotrophicum
IL88963A0 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
Bruton The infrastructure of valyl-transfer Ribonucleic Acid synthetase from yeast.
Fahrenholz et al. Synthesis and biological activities of arginine-vasopressin analogues with reactive groups
Peeters et al. Structural studies on rat prostatic binding protein: The primary structure of component C1 from subunit F
Crumpton et al. The C-terminal antigenic site of sperm-whale myoglobin: the immunological activities of synthetic peptides related to the C-terminus of myoglobin.
Habuchi et al. Sea urchin egg receptor for sperm: the oligosaccharide chains stabilize sperm binding
Morley et al. MPF analogue with high stability to proteolysis
ATE202363T1 (de) Antibiotische peptide aus der kuhmilch
ATE85077T1 (de) Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung.
Needleman et al. Sequencing peptides and proteins lacking free α-amino groups
MX2023005771A (es) Tetrapeptido y composiciones que comprenden tetrapeptidos.
MX2023005770A (es) Tetrapeptido y composiciones que comprenden tetrapeptidos.
Woolley The soluble c‐type cytochromes from the bacterium Aquaspirillum itersonii: The complete amino acid sequence of the cytochrome c‐550
Liébecq Abbreviated designation of amino acid derivatives and peptides

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
FF Patent granted
KB Patent renewed
KB Patent renewed